West Pharmaceutical Services (WST)
EBITDA Growth
14.47%
TTM · Period ending:
WST EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported14.47%period ending
Latest reported14.47%period ending
WST TTM EBITDA YoY % (4.36% → 14.47%)
Year-over-year change
High-resolution chart · PNG
WST ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -45.9337% | |
| -55.2284% | |
| -48.8442% | |
| -37.5783% | |
| 2.6275% | |
| 174.3733% | |
| 206.1538% | |
| 187.6877% | |
| 4.8622% | |
| -40.5629% | |
| -45.1014% | |
| -40.3226% | |
| 15.7598% | |
| 24.2798% | |
| 30.9735% | |
| 23.4513% | |
| 10.352% | |
| 0.8299% | |
| -9.4188% | |
| -7.7551% | |
| 2.5478% | |
| 0.6263% | |
| 5.9448% | |
| 8.1678% | |
| 14.5985% | |
| 27.7333% | |
| 29.3956% | |
| 21.7742% | |
| 4.3147% | |
| 535.5932% | |
| 561.8182% | |
| 2,761.5385% | |
| 3,383.3333% | |
| -76.0163% | |
| -75.8772% | |
| -93.7799% | |
| -105.5814% | |
| 114.3106% | |
| 121.0721% | |
| 160.5797% | |
| -40.4432% | |
| -468.8841% | |
| -334.1991% | |
| -183.7379% | |
| 18.75% | |
| -16.6369% | |
| 5.2392% | |
| 10.4558% | |
| 1.6722% | |
| 29.6984% | |
| 1.8561% | |
| -5.5696% | |
| -2.9221% | |
| -22.482% | |
| 4.3584% |